PPTA members produce in approximately 80 percent of the plasma protein therapies used in the United States today and more than 60 percent worldwide.
North America Members
Access Plasma LLC
B Positive National Blood Services LLC
BioLife Plasma Services
Blood and Plasma Research Inc.
The Interstate Companies
Plasmapunkt Favoriten GmbH
Ruhr-Plasma-Zentrum Bochum GmbH
Southern Blood Services
Abbott Laboratories Diagnostic Division
Blood Group Alliance
Lychem International Ltd.
Marketing Research Bureau, Inc.
Therapure Biopharma Inc.
IQPP Standards Public Comment Period Open +
In accordance with the procedures for developing PPTA Voluntary Standards, these documents are hereby issued for public review, from October 24, 2013 – January 2, 2014. These are proposed revisions to the current IQPP Standards. The following draft documents are issued for public review:Read More
Plasma Donors and Rare Diseases Take Center Stage +Read More
Industry, Donors and Patients to Convene in Vienna +
Brussels, Belgium—The Plasma Protein Therapeutics Association (PPTA), together with Pharmig and IG Plasma are sponsoring a workshop as part of International Plasma Awareness Week, October 13-20. This event is a joint initiative of PPTA and its member companies designed to:Read More
The Source, the international magazine of the plasma protein therapeutics industry is published quarterly.
Read the current issue.